Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Jørn Henrik, Vold"'
Autor:
Karl Trygve Druckrey-Fiskaaen, Jørn Henrik Vold, Tesfaye Madebo, Håvard Midgard, Olav Dalgard, Rafael Alexander Leiva, Lars T. Fadnes, for the INTRO-HCV Study Group
Publikováno v:
Substance Abuse Treatment, Prevention, and Policy, Vol 19, Iss 1, Pp 1-11 (2024)
Abstract Background Persons with opioid use disorders (OUD) and persons with substance use disorders (SUD) who inject substances have a reduced life expectancy of up to 25 years compared with the general population. Chronic liver diseases are a subst
Externí odkaz:
https://doaj.org/article/d694804c641d46cd8db40f37ed00b3e0
Autor:
Einar Furulund, Tesfaye Madebo, Karl Trygve Druckrey-Fiskaaen, Jørn Henrik Vold, Mette Hegland Nordbotn, Eivin Dahl, Sindre M. Dyrstad, Torgeir Gilje Lid, Lars T. Fadnes, for the ATLAS4LAR study group
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-9 (2024)
Abstract Background Substance use disorder is associated with unhealthy lifestyle choices, resulting in adverse social and health consequences. People with opioid use disorder receiving opioid agonist therapy, in particular, have high morbidity and r
Externí odkaz:
https://doaj.org/article/3475dda19bc8430481cf24061b573411
Autor:
Silvia Eiken Alpers, Karl Trygve Druckrey-Fiskaaen, Tesfaye Madebo, Jørn Henrik Vold, Ståle Pallesen, Jens Christoffer Skogen, Linn-Heidi Lunde, Silje Mæland, Lars Thore Fadnes
Publikováno v:
BMC Public Health, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background The COVID-19 pandemic and other life events may trigger worries and psychological distress. These impacts may lead to unhealthy behaviors, such as tobacco smoking, but the degree of such associations is unclear. The current three-
Externí odkaz:
https://doaj.org/article/8d83ba63c4a947ebac95c11fb4ec756d
Autor:
Karl Trygve Druckrey-Fiskaaen, Tesfaye Madebo, Jan Tore Daltveit, Jørn Henrik Vold, Einar Furulund, Torgeir Gilje Lid, Lars Thore Fadnes
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-6 (2024)
Abstract This protocol paper presents an updated statistical analysis plan of the protocol of a randomised controlled trial. The randomised controlled trial investigates the effect of integrating smoking cessation interventions at outpatient opioid a
Externí odkaz:
https://doaj.org/article/f534597e046f4fd1b31a776221d12240
Autor:
Christer F. Aas, Jørn Henrik Vold, Fatemeh Chalabianloo, Else-Marie Løberg, Aaron G. Lim, Peter Vickerman, Kjell Arne Johansson, Lars Thore Fadnes
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-8 (2024)
Abstract People with substance use disorders (SUD) have a high prevalence of chronic hepatitis C virus (HCV) infection and mental health disorders. We aimed to assess the impact of integrated HCV treatment on psychological distress measured by Hopkin
Externí odkaz:
https://doaj.org/article/ba4229bfddac47968f2f29a8d3021973
Autor:
Jørn Henrik Vold, Anne Halmøy, Fatemeh Chalabianloo, Marianne Cook Pierron, Else-Marie Løberg, Kjell Arne Johansson, Lars Thore Fadnes
Publikováno v:
BMC Psychiatry, Vol 23, Iss 1, Pp 1-12 (2023)
Abstract Background Attention-deficit/hyperactivity disorder (ADHD) symptoms may challenge sufficient treatment of substance use and mental disorders. The literature on the extent of such symptoms among patients receiving opioid agonist therapy (OAT)
Externí odkaz:
https://doaj.org/article/63c57f954c3c4b7e809d845801a56c98
Autor:
Jørn Henrik Vold, Fatemeh Chalabianloo, Else-Marie Løberg, Christer F. Aas, Aaron G. Lim, Peter Vickerman, Kjell Arne Johansson, Lars Thore Fadnes
Publikováno v:
Substance Abuse Treatment, Prevention, and Policy, Vol 18, Iss 1, Pp 1-11 (2023)
Abstract Background Most people who inject drugs (PWIDs) suffer from severe fatigue, and chronic hepatitis C virus (HCV) infection may play a role in this. However, there is scarce evidence about interventions that alleviate fatigue among PWIDs. The
Externí odkaz:
https://doaj.org/article/66fc958e921d4256bf8dff3d3ad16e85
Autor:
Karl Trygve Druckrey-Fiskaaen, Einar Furulund, Tesfaye Madebo, Siv-Elin Leirvåg Carlsen, Lars T. Fadnes, Torgeir Gilje Lid, for ATLAS4LAR Study Group, Vibeke Bråthen Buljovcic, Jan Tore Daltveit, Trude Fondenes, Per Gundersen, Beate Haga Trettenes, Mette Hegland Nordbotn, Maria Olsvold, Marianne Cook Pierron, Christine Sundal, Jørn Henrik Vold, Maren Borsheim Bergsaker, Eivin Dahl, Tone Lise Eielsen, Torhild Fiskå, Marianne Larssen, Eirik Holder, Ewa Joanna Wilk, Mari Thoresen Soot
Publikováno v:
Frontiers in Psychiatry, Vol 14 (2023)
IntroductionSmoking-related diseases are major contributors to disability and shorter life expectancy among opioid-dependent patients. Smoking prevalence is considerably higher for opioid-dependent persons than among the general population, and only
Externí odkaz:
https://doaj.org/article/1eb790fdbc254820965bb5e36bf45734
Autor:
Lars T. Fadnes, Einar Furulund, Karl Trygve Druckrey-Fiskaaen, Tesfaye Madebo, Jørn Henrik Vold, Maria Olsvold, Marianne Cook Pierron, Siv-Elin Leirvåg Carlsen, Rune Blomhoff, Torgeir Gilje Lid, for the ATLAS4LAR Study Group
Publikováno v:
BMC Nutrition, Vol 8, Iss 1, Pp 1-6 (2022)
Abstract Background People with substance use disorders generally have unhealthy diets, including limited intake of fruit and vegetables. Evidence shows substantial health benefits from increasing fruit and vegetable consumption on various indicators
Externí odkaz:
https://doaj.org/article/21078be2f0e7429ba0a8e96ddc274713
Autor:
Karl Trygve Druckrey-Fiskaaen, Einar Furulund, Jan Tore Daltveit, Jørn Henrik Vold, Torgeir Gilje Lid, Tesfaye Madebo, Lars Thore Fadnes, for the ATLAS4LAR Study Group
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-11 (2022)
Abstract Background About 85% of patients receiving opioid agonist therapy (OAT) for opioid dependence are smoking tobacco. Although smoke-related pulmonary diseases are significant contributors to morbidity and mortality, few smoking cessation inter
Externí odkaz:
https://doaj.org/article/8ce36699f29945a4a813299a3247b7bb